Analyze of Risk Factors Affecting the Outcomes of Docetaxel-prednisone Combination in the Treatment of Metastatic Castration-resistant Prostate Cancer


ARSLAN B., AKBULUT M. F., ONUK Ö., HAZAR A. İ., ÖZKAN A., GEZMİŞ C. T., ...Daha Fazla

British Journal of Medicine and Medical Research, cilt.15, sa.5, ss.1-8, 2016 (Scopus) identifier identifier